Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Shoushtari
    Shoushtari
  8. Cheung
    Cheung
  9. Voss
    Voss
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (560)
  2. Solid Tumor Oncology Division (456)
  3. GSK Faculty (293)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (157)
  6. Hematologic Malignancies, Division of (155)
  7. Epidemiology and Biostatistics (152)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (120)
  10. Surgery (119)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (560)
  2. Solid Tumor Oncology Division (456)
  3. GSK Faculty (293)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (157)
  6. Hematologic Malignancies, Division of (155)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Sandra D'Angelo (25)

More People

Years
  1. 2025 (33)
  2. 2024 (60)
  3. 2023 (44)
  4. 2022 (122)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (407)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (47)
  5. Journal of Hematology & Oncology (43)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
    Journal Article

    Delavar, A.; Boutros, C.; Barnea, D, ; Schaffer, W. L.; Tonorezos, E. S.
    Cardio-Oncology (2022)

    Fulltext@MSK | Save
  • Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
    Journal Article

    Gomez-Roca, C.; Cassier, P.; Zamarin, D.; Machiels, J. P.; Perez Gracia, J. L.; Hodi, F. S.; Taus, A.; Martinez Garcia, M.; Boni, V.; Eder, J. P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
    Review

    Ascierto, P. A.; Butterfield, L. H.; Finn, O. J.; Futreal, A.; Hamid, O.; LaVallee, T.; Postow, M. A.; Puzanov, I.; Sosman, J.; Fox, B. A.; more...
    Journal of Translational Medicine (2022)

    Fulltext@MSK | Save
  • The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
    Review

    Ascierto, P. A.; Warner, A. B.; Blank, C.; Caracò, C.; Demaria, S.; Gershenwald, J. E.; Khushalani, N. I.; Long, G. V.; Luke, J. J.; Mehnert, J. M.; more...
    Journal of Translational Medicine (2022)

    Fulltext@MSK | Save
  • Phase 3 randomized trial comparing tebentafusp with investigator's choice in first line metastatic uveal melanoma
    Meeting Abstract

    Piperno-Neumann, S.; Hassel, J. C.; Rutkowski, P.; Baurain, J. F.; Butler, M. O.; Schlaak, M.; Sullivan, R. J.; Ochsenreither, S.; Dummer, R.; Kirkwood, J. M.; more...
    Journal of Translational Medicine (2022)

    Fulltext@MSK | Save
  • Co-primary endpoint of overall survival for tebentafusp (tebe)-induced rash in a phase 3 randomized trial comparing tebe vs. investigator's choice (IC) in first line metastatic uveal melanoma
    Meeting Abstract

    Hassel, J. C.; Rutkowski, P.; Baurain, J. F.; Butler, M. O.; Schlaak, M.; Sullivan, R. J.; Ochsenreither, S.; Dummer, R.; Kirkwood, J. M.; Joshua, A. M.; more...
    Journal of Translational Medicine (2022)

    Fulltext@MSK | Save
  • Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
    Journal Article

    Rosenbaum, E.; Antonescu, C. R.; Smith, S.; Bradic, M.; Kashani, D.; Richards, A. L.; Donoghue, M.; Kelly, C. M.; Nacev, B.; Chan, J. E.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial
    Journal Article

    El-Khoueiry, A. B.; Meyer, T.; Cheng, A. L.; Rimassa, L.; Sen, S.; Milwee, S.; Kelley, R. K.; Abou-Alfa, G. K.
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
    Journal Article

    ten Hoorn, S.; Waasdorp, C.; van Oijen, M. G. H.; Damhofer, H.; Trinh, A.; Zhao, L.; Smits, L. J. H.; Bootsma, S.; van Pelt, G. W.; Mesker, W. E.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Adaptation and validation of the Chinese version of the lung cancer screening health belief scales
    Journal Article

    Lin, Y. A.; Carter-Harris, L.; Yang, J. N.; Lin, X. J.; Huang, F. F.
    BMC Public Health (2022)

    Fulltext@MSK | Save